Echinocandin antifungal drugs

DW Denning - The Lancet, 2003 - thelancet.com
The echinocandins are large lipopeptide molecules that are inhibitors of β-(1, 3)-glucan
synthesis, an action that damages fungal cell walls. In vitro and in vivo, the echinocandins …

Infections due to emerging and uncommon medically important fungal pathogens

TJ Walsh, A Groll, J Hiemenz, R Fleming… - Clinical Microbiology …, 2004 - Wiley Online Library
The emergence of less common but medically important fungal pathogens contributes to the
rate of morbidity and mortality, especially in the increasingly expanding population of …

Guidelines for treatment of candidiasis

PG Pappas, JH Rex, JD Sobel, SG Filler… - Clinical infectious …, 2004 - academic.oup.com
Candida species are the most common cause of fungal infections. Candida species produce
infections that range from non—life-threatening mucocutaneous illnesses to invasive …

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis

PG Pappas, CMF Rotstein, RF Betts… - Clinical infectious …, 2007 - academic.oup.com
Background. Invasive candidiasis is an important cause of morbidity and mortality among
patients with health care–associated infection. The echinocandins have potent fungicidal …

Human fusariosis

MC Dignani, E Anaissie - Clinical Microbiology and Infection, 2004 - Wiley Online Library
Fusarium species frequently implicated in human infections include F. solani, F. oxysporum
and F. moniliforme. Among immunocompetent patients, tissue breakdown (as caused by …

Invasive Infections Caused by Trichosporon Species and Geotrichum capitatum in Patients with Hematological Malignancies: a Retrospective Multicenter Study from …

C Girmenia, L Pagano, B Martino… - Journal of clinical …, 2005 - Am Soc Microbiol
Trichosporonosis is an uncommon but frequently fatal mycosis in immunocompromised
patients. A multicenter retrospective study was conducted to characterize cases of proven or …

Invasive fungal infections in the ICU: how to approach, how to treat

E Paramythiotou, F Frantzeskaki, A Flevari… - Molecules, 2014 - mdpi.com
Invasive fungal infections are a growing problem in critically ill patients and are associated
with increased morbidity and mortality. Most of them are due to Candida species, especially …

Pharmacology of systemic antifungal agents

ESD Ashley, R Lewis, JS Lewis… - Clinical infectious …, 2006 - academic.oup.com
Traditionally, many invasive fungal infections were associated with a poor prognosis,
because effective therapeutic options were limited. The recent development of new …

Uncommon opportunistic fungi: new nosocomial threats

AH Groll, TJ Walsh - Clinical Microbiology and Infection, 2001 - Wiley Online Library
During the past two decades opportunistic fungal infections have emerged as important
causes of morbidity and mortality in patients with severe underlying illnesses and …

Newer systemic antifungal agents: pharmacokinetics, safety and efficacy

HW Boucher, AH Groll, CC Chiou, TJ Walsh - Drugs, 2004 - Springer
The past few years have seen the advent of several new antifungal agents, including those
of a new class and a new generation of an existing class. Caspofungin, the first available …